Physician profile
Robert W Jones
NPI 1821035569
$7,886.47
in general payments reported to CMS, 2019-2025
23 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,194 · 2020: $498 · 2021: $1,396 · 2022: $1,157 · 2023: $1,303 · 2024: $1,095 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,543 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.05 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,841.26 | 2019-2024 | Clareon, Hydrus Microstent, Argos |
| Biotissue Holdings INC. | $1,210.65 | 2019-2023 | |
| Allergan, INC. | $970.67 | 2019-2022 | |
| Abbvie INC. | $619.24 | 2022-2025 | |
| Genentech USA, INC. | $588.92 | 2019-2024 | Vabysmo |
| Ivantis, INC | $450.98 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $356.65 | 2022-2025 | Acthar |
| Glaukos Corporation | $299.51 | 2019-2024 | Idose |
| Bausch & Lomb Americas INC. | $230.99 | 2022-2024 | Vyzulta, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $225.06 | 2021-2023 | Tecnis Simplicity |
| Sight Sciences, INC. | $223.28 | 2019-2024 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $151.16 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $115.67 | 2019-2022 | |
| Alimera Sciences, INC. | $112.41 | 2023-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $101.42 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $86.60 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $72.00 | 2025 | Comprehensive Shoulder System |
| Rxsight INC | $57.52 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Vantage Technology LLC | $47.21 | 2020-2023 | |
| Dompe US, INC. | $41.22 | 2023-2024 | Oxervate |
| Aerie Pharmaceuticals, INC. | $39.99 | 2019-2021 | |
| Depuy Synthes Sales INC. | $27.95 | 2019 | |
| Apellis Pharmaceuticals, INC. | $16.11 | 2024 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.